ITGAM and Arthritis: On the other hand, blocking CD11b immediately before onset of disease significantly reduced disease burden in two different models of arthritis (CIA and a DBA/1 to severe combined immunodeficiency transfer model of arthritis) (100), suggesting that the role of CD11b in inflammatory arthritis may differ depending on the cell type involved and the disease stage.